Vertex Pharmaceuticals Newsroom

After experiencing a bumper harvest in 2024, the USA ETF may encounter setbacks this year.

The USA Exchange Traded Fund (ETF) received a record inflow of $1.1 trillion in 2024, but entering 2025, rapid growth may face more obstacles.

Zhitong FinanceJan 2 20:49

Revenues Not Telling The Story For Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Simply Wall StJan 1 21:23

Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors

Zacks Jan 1 06:20

Those Who Invested in Vertex Pharmaceuticals (NASDAQ:VRTX) Three Years Ago Are up 79%

Yahoo FinanceDec 31, 2024 19:00

Is the Options Market Predicting a Spike in Vertex Pharmaceuticals (VRTX) Stock?

Zacks Dec 30, 2024 20:35

10 Health Care Stocks With Whale Alerts In Today's Session

BenzingaDec 27, 2024 01:35

Vertex Pharmaceuticals Stock Is Down 13%. Here's Why You Should Buy the Dip

Yahoo FinanceDec 26, 2024 21:30

Express News | JPMorgan: Downgraded the Target Price of Vertex Pharmaceuticals from $503 to $500, but maintained the Shareholding rating.

BreakingsDec 26, 2024 14:36

Jim Cramer on Vertex Pharmaceuticals Incporated (VRTX): 'This Is Hardly Down For The Year. I Think It Can Still Go Lower'

Yahoo FinanceDec 25, 2024 20:51

Analysts Are Bullish on Top Healthcare Stocks: Oruka Therapeutics (ORKA), Vertex Pharmaceuticals (VRTX)

TipRanksDec 25, 2024 20:01 · Ratings

Truist Financial Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $460

Futu NewsDec 25, 2024 19:32 · Ratings

Will Vertex Pharmaceuticals Incorporated (VRTX) Make You Rich In 2025?

Yahoo FinanceDec 25, 2024 12:02

Vertex Pharmaceuticals (VRTX) Gains But Lags Market: What You Should Know

Yahoo FinanceDec 25, 2024 06:50

Top Stock Reports for T-Mobile, Toyota Motor & Vertex Pharmaceuticals

Zacks Dec 25, 2024 03:00

Vertex Pharmaceuticals Price Target Lowered to $460 From $550 at Truist

Yahoo FinanceDec 24, 2024 22:50

Truist has lowered the Vertex Target Price to 460 dollars.

Truist: lowered the Target Price of Vertex Pharmaceuticals from $550 to $460, maintaining a Buy rating. (Gelonghui)

Gelonghui FinanceDec 24, 2024 21:24 · Ratings

A Quick Look at Today's Ratings for Vertex Pharmaceuticals(VRTX.US), With a Forecast Between $430 to $525

Futu NewsDec 24, 2024 21:00 · Ratings

Vertex to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13

BusinesswireDec 24, 2024 05:05

Vertex Secures FDA Approval for New Cystic Fibrosis Drug Alyftrek

Zacks Dec 24, 2024 02:00

Vertex Pharmaceuticals: Alyftrek Is An 'Accretive Opportunity' On Top- And Bottom-Lines, Says Bullish Analyst

BenzingaDec 24, 2024 00:13